Spots Global Cancer Trial Database for Photobiomodulation Therapy Plus M-health in Head and Neck Cancer Patients: LAXER Study

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Photobiomodulation Therapy Plus M-health in Head and Neck Cancer Patients: LAXER Study

Official Title: Photobiomodulation Therapy With M-health Tool for the Management of Oral Health and Quality of Life in Head and Neck Cancer Patients: LAXER Study

Study ID: NCT05106608

Conditions

Head and Neck Cancer

Head and Neck Neoplasms

Xerostomia

Interventions

Energy density photobiomodulation (7.5)

Energy density photobiomodulation (3)

Sham placebo

Study Description

Brief Summary: The Photobiomodulation therapy could have positive effects on quality of life and oral health in head and neck cancer survivors post-radiotherapy. The improvement in quality of life will be maintained after a follow-up period.

Detailed Description: Many experts advocate the use of Photobiomodulation (PBM) therapy in patients with cancer and demand studies of higher methodological quality such as randomized controlled clinical trials. However, there is no consensus on the most effective dosimetry that allows us to establish an effective and safe approach to treat radiotherapy-induced xerostomia in head and neck cancer survivors. Finally, recent reviews highlight the importance of determining whether or not the effects of Photobiomodulation therapy are maintained after a follow-up period.